Events and Webinars

We’re very sorry that our site is currently unavailable due to unscheduled maintenance. We are working hard to it fix it -- please try back soon.

Related Events and Webinars

May 23, 2019 6:00PM EST

This program will review clinical efficacy and safety data that support the use of LAMA\/LABA or triple therapy for appropriate patients with COPD. The program will last approximately 45 minutes and conclude with an optional Q&A.

Webinar
1h
May 22, 2019 12:15PM EST

This program will review clinical efficacy and safety data that support the use of LAMA\/LABA or triple therapy for appropriate patients with COPD. The program will last approximately 45 minutes and conclude with an optional Q&A.

Webinar
1h 30m
May 21, 2019 12:15PM CST

This program will answer key questions about managing patients with COPD with triple (ICS\/LABA\/LAMA) therapy. It will review clinical efficacy and safety data that support the use of triple therapy for appropriate patients with COPD. The program will la

Webinar
1h 30m
May 16, 2019 6:00PM EST

This program will answer key questions about managing patients with COPD with triple (ICS\/LABA\/LAMA) therapy. It will review clinical efficacy and safety data that support the use of triple therapy for appropriate patients with COPD. The program will la

Webinar
1h 30m
May 16, 2019 12:15PM PST

The objective of this program is to provide Disease State Education on Meningococcal Serogroup B including, Advisory Committee of Immunization Practices recommendations and Meningococcal vaccine information. The program will last 30-40 minutes with an opt

Webinar
1h 30m
May 15, 2019 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h
May 15, 2019 12:15PM CST

This program will review clinical efficacy and safety data that support the use of LAMA\/LABA or triple therapy for appropriate patients with COPD. The program will last approximately 45 minutes and conclude with an optional Q&A.

Webinar
1h 30m
May 09, 2019 12:15PM EST

This program will review clinical efficacy and safety data that support the use of LAMA\/LABA or triple therapy for appropriate patients with COPD. The program will last approximately 45 minutes and conclude with an optional Q&A.

Webinar
1h
May 08, 2019 12:15PM PST

This program will answer key questions about managing patients with COPD with triple (ICS\/LABA\/LAMA) therapy. It will review clinical efficacy and safety data that support the use of triple therapy for appropriate patients with COPD. The program will la

Webinar
1h
May 08, 2019 12:15PM EST

The objective of this program is to provide Disease State Education on Meningococcal Serogroup B including, Advisory Committee of Immunization Practices recommendations and Meningococcal vaccine information. The program will last 30-40 minutes with an opt

Webinar
1h
May 07, 2019 6:00PM EST

This program will answer key questions about managing patients with COPD with triple (ICS\/LABA\/LAMA) therapy. It will review clinical efficacy and safety data that support the use of triple therapy for appropriate patients with COPD. The program will la

Webinar
1h 30m
May 07, 2019 1:15PM CST

The objective of this program is to provide Disease State Education on Meningococcal Serogroup B including, Advisory Committee of Immunization Practices recommendations and Meningococcal vaccine information. The program will last 30-40 minutes with an opt

Webinar
1h 30m
May 01, 2019 12:15PM EST

This program will answer key questions about managing patients with COPD with triple (ICS\/LABA\/LAMA) therapy. It will review clinical efficacy and safety data that support the use of triple therapy for appropriate patients with COPD. The program will la

Webinar
1h
April 30, 2019 6:00PM CST

This program will review clinical efficacy and safety data that support the use of LAMA\/LABA or triple therapy for appropriate patients with COPD. The program will last approximately 45 minutes and conclude with an optional Q&A.

Webinar
1h 30m
April 25, 2019 12:15PM PST

This program will answer key questions about managing patients with COPD with triple (ICS\/LABA\/LAMA) therapy. It will review clinical efficacy and safety data that support the use of triple therapy for appropriate patients with COPD. The program will la

Webinar
1h
April 25, 2019 12:15PM PST

The objective of this program is to provide Disease State Education on Meningococcal Serogroup B including, Advisory Committee of Immunization Practices recommendations and Meningococcal vaccine information. The program will last 30-40 minutes with an opt

Webinar
1h 30m
April 24, 2019 12:15PM CST

The objective of this program is to provide Disease State Education on Meningococcal Serogroup B including, Advisory Committee of Immunization Practices recommendations and Meningococcal vaccine information. The program will last 30-40 minutes with an opt

Webinar
1h
April 24, 2019 12:15PM CST

This program will review clinical efficacy and safety data that support the use of LAMA\/LABA or triple therapy for appropriate patients with COPD. The program will last approximately 45 minutes and conclude with an optional Q&A.

Webinar
1h 30m
April 23, 2019 6:00PM EST

This program will review clinical efficacy and safety data that support the use of LAMA\/LABA or triple therapy for appropriate patients with COPD. The program will last approximately 45 minutes and conclude with an optional Q&A.

Webinar
1h
April 18, 2019 12:15PM CST

This program will review clinical efficacy and safety data that support the use of LAMA\/LABA or triple therapy for appropriate patients with COPD. The program will last approximately 45 minutes and conclude with an optional Q&A.

Webinar
1h 30m
April 17, 2019 12:15PM EST

This program will answer key questions about managing patients with COPD with triple (ICS\/LABA\/LAMA) therapy. It will review clinical efficacy and safety data that support the use of triple therapy for appropriate patients with COPD. The program will la

Webinar
1h 30m
April 16, 2019 6:00PM EST

This program will answer key questions about managing patients with COPD with triple (ICS\/LABA\/LAMA) therapy. It will review clinical efficacy and safety data that support the use of triple therapy for appropriate patients with COPD. The program will la

Webinar
1h
April 16, 2019 12:15PM EST

This program will review clinical efficacy and safety data that support the use of LAMA\/LABA or triple therapy for appropriate patients with COPD. The program will last approximately 45 minutes and conclude with an optional Q&A.

Webinar
1h
April 10, 2019 12:15PM EST

This program will answer key questions about managing patients with COPD with triple (ICS\/LABA\/LAMA) therapy. It will review clinical efficacy and safety data that support the use of triple therapy for appropriate patients with COPD. The program will la

Webinar
1h
April 09, 2019 12:15PM PST

This program will review clinical efficacy and safety data that support the use of LAMA\/LABA or triple therapy for appropriate patients with COPD. The program will last approximately 45 minutes and conclude with an optional Q&A.

Webinar
1h
April 04, 2019 12:15PM PST

The objective of this program is to provide Disease State Education on Meningococcal Serogroup B including, Advisory Committee of Immunization Practices recommendations and Meningococcal vaccine information. The program will last 30-40 minutes with an opt

Webinar
1h 30m
April 03, 2019 12:15PM CST

This program will answer key questions about managing patients with COPD with triple (ICS\/LABA\/LAMA) therapy. It will review clinical efficacy and safety data that support the use of triple therapy for appropriate patients with COPD. The program will la

Webinar
1h
April 02, 2019 12:15PM EST

This program will review clinical efficacy and safety data that support the use of LAMA\/LABA or triple therapy for appropriate patients with COPD. The program will last approximately 45 minutes and conclude with an optional Q&A.

Webinar
2h
March 28, 2019 12:15PM EST

This program will review clinical efficacy and safety data that support the use of LAMA\/LABA or triple therapy for appropriate patients with COPD. The program will last approximately 45 minutes and conclude with an optional Q&A.

Webinar
1h 30m
March 27, 2019 6:30PM PST

The objective of this program is to provide Disease State Education on Meningococcal Serogroup B including, Advisory Committee of Immunization Practices recommendations and Meningococcal vaccine information. The program will last 30-40 minutes with an opt

Webinar
1h 30m
March 27, 2019 6:00PM EST

This program will answer key questions about managing patients with COPD with triple (ICS\/LABA\/LAMA) therapy. It will review clinical efficacy and safety data that support the use of triple therapy for appropriate patients with COPD. The program will la

Webinar
1h
March 26, 2019 6:00PM CST

This program will review clinical efficacy and safety data that support the use of LAMA\/LABA or triple therapy for appropriate patients with COPD. The program will last approximately 45 minutes and conclude with an optional Q&A.

Webinar
1h
March 26, 2019 12:15PM CST

This program will answer key questions about managing patients with COPD with triple (ICS\/LABA\/LAMA) therapy. It will review clinical efficacy and safety data that support the use of triple therapy for appropriate patients with COPD. The program will la

Webinar
1h
March 21, 2019 1:15PM CST

The objective of this program is to provide Disease State Education on Meningococcal Serogroup B including, Advisory Committee of Immunization Practices recommendations and Meningococcal vaccine information. The program will last 30-40 minutes with an opt

Webinar
1h
March 21, 2019 12:15PM EST

This program will answer key questions about managing patients with COPD with triple (ICS\/LABA\/LAMA) therapy. It will review clinical efficacy and safety data that support the use of triple therapy for appropriate patients with COPD. The program will la

Webinar
1h
March 20, 2019 6:00PM CST

This program will review clinical efficacy and safety data that support the use of LAMA\/LABA or triple therapy for appropriate patients with COPD. The program will last approximately 45 minutes and conclude with an optional Q&A.

Webinar
1h
March 20, 2019 12:15PM CST

The objective of this program is to provide Disease State Education on Meningococcal Serogroup B including, Advisory Committee of Immunization Practices recommendations and Meningococcal vaccine information. The program will last 30-40 minutes with an opt

Webinar
1h
March 19, 2019 6:30PM PST

The objective of this program is to provide Disease State Education on Meningococcal Serogroup B including, Advisory Committee of Immunization Practices recommendations and Meningococcal vaccine information. The program will last 30-40 minutes with an opt

Webinar
1h
March 19, 2019 12:15PM PST

This program will answer key questions about managing patients with COPD with triple (ICS\/LABA\/LAMA) therapy. It will review clinical efficacy and safety data that support the use of triple therapy for appropriate patients with COPD. The program will la

Webinar
1h
March 19, 2019 12:15PM PST

The objective of this program is to provide Disease State Education on Meningococcal Serogroup B including, Advisory Committee of Immunization Practices recommendations and Meningococcal vaccine information. The program will last 30-40 minutes with an opt

Webinar
1h
March 14, 2019 12:15PM CST

This program will review clinical efficacy and safety data that support the use of LAMA\/LABA or triple therapy for appropriate patients with COPD. The program will last approximately 45 minutes and conclude with an optional Q&A.

Webinar
2h
March 14, 2019 12:15PM EST

The objective of this program is to provide Disease State Education on Meningococcal Serogroup B including, Advisory Committee of Immunization Practices recommendations and Meningococcal vaccine information. The program will last 30-40 minutes with an opt

Webinar
1h
March 14, 2019 12:00PM EST

The objective of this program is to provide Disease State Education on Meningococcal Serogroup B including, Advisory Committee of Immunization Practices recommendations and Meningococcal vaccine information. The program will last 30-40 minutes with an opt

Webinar
1h
March 13, 2019 6:00PM CST

This program will answer key questions about managing patients with COPD with triple (ICS\/LABA\/LAMA) therapy. It will review clinical efficacy and safety data that support the use of triple therapy for appropriate patients with COPD. The program will la

Webinar
1h
March 13, 2019 12:15PM MST

The objective of this program is to provide Disease State Education on Meningococcal Serogroup B including, Advisory Committee of Immunization Practices recommendations and Meningococcal vaccine information. The program will last 30-40 minutes with an opt

Webinar
1h
March 13, 2019 12:15PM EST

This program will answer key questions about managing patients with COPD with triple (ICS\/LABA\/LAMA) therapy. It will review clinical efficacy and safety data that support the use of triple therapy for appropriate patients with COPD. The program will la

Webinar
1h
March 12, 2019 12:15PM CST

This program will review clinical efficacy and safety data that support the use of LAMA\/LABA or triple therapy for appropriate patients with COPD. The program will last approximately 45 minutes and conclude with an optional Q&A.

Webinar
1h
March 07, 2019 6:00PM EST

This program will review clinical efficacy and safety data that support the use of LAMA\/LABA or triple therapy for appropriate patients with COPD. The program will last approximately 45 minutes and conclude with an optional Q&A.

Webinar
1h 30m
March 07, 2019 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h
March 06, 2019 1:15PM CST

The objective of this program is to provide Disease State Education on Meningococcal Serogroup B including, Advisory Committee of Immunization Practices recommendations and Meningococcal vaccine information. The program will last 30-40 minutes with an opt

Webinar
1h 30m
March 05, 2019 1:15PM PST

The objective of this program is to provide Disease State Education on Meningococcal Serogroup B including, Advisory Committee of Immunization Practices recommendations and Meningococcal vaccine information. The program will last 30-40 minutes with an opt

Webinar
1h
February 27, 2019 12:15PM CST

This program will answer key questions about managing patients with COPD with triple (ICS\/LABA\/LAMA) therapy. It will review clinical efficacy and safety data that support the use of triple therapy for appropriate patients with COPD. The program will la

Webinar
1h
February 26, 2019 6:00PM EST

This program will answer key questions about managing patients with COPD with triple (ICS\/LABA\/LAMA) therapy. It will review clinical efficacy and safety data that support the use of triple therapy for appropriate patients with COPD. The program will la

Webinar
1h
February 26, 2019 12:15PM EST

This program will answer key questions about managing patients with COPD with triple (ICS\/LABA\/LAMA) therapy. It will review clinical efficacy and safety data that support the use of triple therapy for appropriate patients with COPD. The program will la

Webinar
1h
February 21, 2019 6:00PM PST

This program will answer key questions about managing patients with COPD with triple (ICS\/LABA\/LAMA) therapy. It will review clinical efficacy and safety data that support the use of triple therapy for appropriate patients with COPD. The program will la

Webinar
1h
February 21, 2019 12:15PM CST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h 30m
February 20, 2019 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h
February 20, 2019 12:15PM EST

The objective of this program is to provide Disease State Education on Meningococcal Serogroup B including, Advisory Committee of Immunization Practices recommendations and Meningococcal vaccine information. The program will last 30-40 minutes with an opt

Webinar
1h
February 19, 2019 12:15PM CST

This program will answer key questions about managing patients with COPD with triple (ICS\/LABA\/LAMA) therapy. It will review clinical efficacy and safety data that support the use of triple therapy for appropriate patients with COPD. The program will la

Webinar
1h
February 19, 2019 12:15PM CST

The objective of this program is to provide Disease State Education on Meningococcal Serogroup B including, Advisory Committee of Immunization Practices recommendations and Meningococcal vaccine information. The program will last 30-40 minutes with an opt

Webinar
1h
February 14, 2019 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h
February 14, 2019 12:15PM EST

This program will review clinical efficacy and safety data that support the use of LAMA\/LABA or triple therapy for appropriate patients with COPD. The program will last approximately 45 minutes and conclude with an optional Q&A.

Webinar
1h 30m
February 13, 2019 12:15PM PST

The objective of this program is to provide Disease State Education on Meningococcal Serogroup B including, Advisory Committee of Immunization Practices recommendations and Meningococcal vaccine information. The program will last 30-40 minutes with an opt

Webinar
1h 30m
February 07, 2019 12:15PM EST

The objective of this program is to provide Disease State Education on Meningococcal Serogroup B including, Advisory Committee of Immunization Practices recommendations and Meningococcal vaccine information. The program will last 30-40 minutes with an opt

Webinar
2h
February 06, 2019 12:15PM MST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h
February 05, 2019 1:15PM CST

The objective of this program is to provide Disease State Education on Meningococcal Serogroup B including, Advisory Committee of Immunization Practices recommendations and Meningococcal vaccine information. The program will last 30-40 minutes with an opt

Webinar
1h
February 05, 2019 12:15PM CST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h
January 31, 2019 12:15PM PST

The objective of this program is to provide Disease State Education on Meningococcal Serogroup B including, Advisory Committee of Immunization Practices recommendations and Meningococcal vaccine information. The program will last 30-40 minutes with an opt

Webinar
1h
January 30, 2019 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h
January 29, 2019 1:15PM CST

The objective of this program is to provide Disease State Education on Meningococcal Serogroup B including, Advisory Committee of Immunization Practices recommendations and Meningococcal vaccine information. The program will last 30-40 minutes with an opt

Webinar
1h 30m
January 24, 2019 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h
January 22, 2019 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h
January 22, 2019 12:15PM EST

The objective of this program is to provide Disease State Education on Meningococcal Serogroup B including, Advisory Committee of Immunization Practices recommendations and Meningococcal vaccine information. The program will last 30-40 minutes with an opt

Webinar
1h
January 17, 2019 9:00PM EST

This program provides an opportunity to learn about a rare disease, EGPA (previously known as Churg-Strauss syndrome). You will learn about the history of the disease, its complex pathogenesis, and its diverse clinical manifestations. The program will las

Webinar
1h
January 17, 2019 12:15PM PST

The objective of this program is to provide Disease State Education on Meningococcal Serogroup B including, Advisory Committee of Immunization Practices recommendations and Meningococcal vaccine information. The program will last 30-40 minutes with an opt

Webinar
1h 30m
December 13, 2018 6:30PM EST

This program will feature an interactive, case-based discussion about managing severe asthma with a national medical expert. It will also include a review of the role of eosinophils in severe asthma and discuss long-term safety and efficacy data for NUCAL

Webinar
1h
December 13, 2018 12:15PM MST

The objective of this program is to provide Disease State Education on Meningococcal Serogroup B including, Advisory Committee of Immunization Practices recommendations and Meningococcal vaccine information. The program will last 30-40 minutes with an opt

Webinar
1h
December 12, 2018 1:15PM PST

The objective of this program is to provide Disease State Education on Meningococcal Serogroup B including, Advisory Committee of Immunization Practices recommendations and Meningococcal vaccine information. The program will last 30-40 minutes with an opt

Webinar
1h
December 11, 2018 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h
December 11, 2018 12:15PM EST

The objective of this program is to provide Disease State Education on Meningococcal Serogroup B including, Advisory Committee of Immunization Practices recommendations and Meningococcal vaccine information. The program will last 30-40 minutes with an opt

Webinar
1h
December 10, 2018 7:00PM EST

This program will feature an interactive, case-based discussion about managing severe asthma with a national medical expert. It will also include a review of the role of eosinophils in severe asthma and discuss long-term safety and efficacy data for NUCAL

Webinar
1h
December 05, 2018 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h
December 05, 2018 12:15PM CST

The objective of this program is to provide Disease State Education on Meningococcal Serogroup B including, Advisory Committee of Immunization Practices recommendations and Meningococcal vaccine information. The program will last 30-40 minutes with an opt

Webinar
1h 30m
December 04, 2018 12:30PM EST

This program will answer key questions about managing patients with COPD with triple (ICS/LABA/LAMA) therapy. It will review clinical efficacy and safety data that support the use of triple therapy for appropriate patients with COPD. The program w

Webinar
1h
December 03, 2018 7:00PM EST

This program will feature an interactive, case-based discussion about managing severe asthma with a national medical expert. It will also include a review of the role of eosinophils in severe asthma and discuss long-term safety and efficacy data for NUCAL

Webinar
1h
November 29, 2018 12:15PM CST

The objective of this program is to provide Disease State Education on Meningococcal Serogroup B including, Advisory Committee of Immunization Practices recommendations and Meningococcal vaccine information. The program will last 30-40 minutes with an opt

Webinar
1h
November 28, 2018 12:00PM EST

This program will answer key questions about managing patients with COPD with triple (ICS/LABA/LAMA) therapy. It will review clinical efficacy and safety data that support the use of triple therapy for appropriate patients with COPD. The program w

Webinar
1h
November 27, 2018 12:15PM EST

The objective of this program is to provide Disease State Education on Meningococcal Serogroup B including, Advisory Committee of Immunization Practices recommendations and Meningococcal vaccine information. The program will last 30-40 minutes with an opt

Webinar
1h
November 15, 2018 12:15PM PST

The objective of this program is to provide Disease State Education on Meningococcal Serogroup B including, Advisory Committee of Immunization Practices recommendations and Meningococcal vaccine information. The program will last 30-40 minutes with an opt

Webinar
1h
November 15, 2018 12:00PM CST

This program will answer key questions about managing patients with COPD with triple (ICS/LABA/LAMA) therapy. It will review clinical efficacy and safety data that support the use of triple therapy for appropriate patients with COPD. The program w

Webinar
1h
November 14, 2018 12:15PM CST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h
November 14, 2018 12:15PM CST

The objective of this program is to provide Disease State Education on Meningococcal Serogroup B including, Advisory Committee of Immunization Practices recommendations and Meningococcal vaccine information. The program will last 30-40 minutes with an opt

Webinar
1h
November 13, 2018 6:30PM EST

This program will answer key questions about managing patients with COPD with triple (ICS/LABA/LAMA) therapy. It will review clinical efficacy and safety data that support the use of triple therapy for appropriate patients with COPD. The program w

Webinar
1h
November 13, 2018 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h
November 13, 2018 12:30PM EST

This program will answer key questions about managing patients with COPD with triple (ICS/LABA/LAMA) therapy. It will review clinical efficacy and safety data that support the use of triple therapy for appropriate patients with COPD. The program w

Webinar
1h
November 08, 2018 12:15PM MST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h
November 07, 2018 6:30PM PST

The objective of this program is to provide Disease State Education on Meningococcal Serogroup B including, Advisory Committee of Immunization Practices recommendations and Meningococcal vaccine information. The program will last 30-40 minutes with an opt

Webinar
1h 30m
November 07, 2018 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h
November 07, 2018 12:15PM EST

The objective of this program is to provide Disease State Education on Meningococcal Serogroup B including, Advisory Committee of Immunization Practices recommendations and Meningococcal vaccine information. The program will last 30-40 minutes with an opt

Webinar
1h 30m
November 06, 2018 6:30PM CST

This program will answer key questions about managing patients with COPD with triple (ICS/LABA/LAMA) therapy. It will review clinical efficacy and safety data that support the use of triple therapy for appropriate patients with COPD. The program w

Webinar
1h
October 30, 2018 6:30PM EST

This program will answer key questions about managing patients with COPD with triple (ICS/LABA/LAMA) therapy. It will review clinical efficacy and safety data that support the use of triple therapy for appropriate patients with COPD. The program w

Webinar
1h
October 25, 2018 6:30PM EST

This program will answer key questions about managing patients with COPD with triple (ICS/LABA/LAMA) therapy. It will review clinical efficacy and safety data that support the use of triple therapy for appropriate patients with COPD. The program w

Webinar
1h
October 25, 2018 12:15PM PST

The objective of this program is to provide Disease State Education on Meningococcal Serogroup B including, Advisory Committee of Immunization Practices recommendations and Meningococcal vaccine information. The program will last 30-40 minutes with an opt

Webinar
1h
October 24, 2018 7:00PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h
October 24, 2018 12:15PM CST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h
October 24, 2018 12:15PM CST

The objective of this program is to provide Disease State Education on Meningococcal Serogroup B including, Advisory Committee of Immunization Practices recommendations and Meningococcal vaccine information. The program will last 30-40 minutes with an opt

Webinar
1h
October 24, 2018 12:30PM EST

This program will answer key questions about managing patients with COPD with triple (ICS/LABA/LAMA) therapy. It will review clinical efficacy and safety data that support the use of triple therapy for appropriate patients with COPD. The program w

Webinar
1h
October 18, 2018 12:30PM CST

This program will answer key questions about managing patients with COPD with triple (ICS/LABA/LAMA) therapy. It will review clinical efficacy and safety data that support the use of triple therapy for appropriate patients with COPD. The program w

Webinar
1h
October 18, 2018 12:15PM CST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
2h
October 17, 2018 7:00PM EST

This program will answer key questions about managing patients with COPD with triple (ICS/LABA/LAMA) therapy. It will review clinical efficacy and safety data that support the use of triple therapy for appropriate patients with COPD. The program w

Webinar
1h
October 17, 2018 12:15PM MST

The objective of this program is to provide Disease State Education on Meningococcal Serogroup B including, Advisory Committee of Immunization Practices recommendations and Meningococcal vaccine information. The program will last 30-40 minutes with an opt

Webinar
1h
October 16, 2018 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h
October 11, 2018 1:15PM PST

The objective of this program is to provide Disease State Education on Meningococcal Serogroup B including, Advisory Committee of Immunization Practices recommendations and Meningococcal vaccine information. The program will last 30-40 minutes with an opt

Webinar
1h
October 11, 2018 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h
October 11, 2018 12:30PM EST

This program will answer key questions about managing patients with COPD with triple (ICS/LABA/LAMA) therapy. It will review clinical efficacy and safety data that support the use of triple therapy for appropriate patients with COPD. The program w

Webinar
1h
October 09, 2018 12:00PM CST

This program will answer key questions about managing patients with COPD with triple (ICS/LABA/LAMA) therapy. It will review clinical efficacy and safety data that support the use of triple therapy for appropriate patients with COPD. The program w

Webinar
1h
October 09, 2018 12:15PM EST

The objective of this program is to provide Disease State Education on Meningococcal Serogroup B including, Advisory Committee of Immunization Practices recommendations and Meningococcal vaccine information. The program will last 30-40 minutes with an opt

Webinar
1h
September 27, 2018 12:15PM CST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h
September 20, 2018 12:15PM MST

The objective of this program is to provide Disease State Education on Meningococcal Serogroup B including, Advisory Committee of Immunization Practices recommendations and Meningococcal vaccine information. The program will last 30-40 minutes with an opt

Webinar
1h
September 20, 2018 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h
September 19, 2018 12:15PM CST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h
September 18, 2018 1:15PM PST

The objective of this program is to provide Disease State Education on Meningococcal Serogroup B including, Advisory Committee of Immunization Practices recommendations and Meningococcal vaccine information. The program will last 30-40 minutes with an opt

Webinar
1h
September 12, 2018 12:15PM MST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h